The Latest Articles from Streetwise Reports


News Update

Cannabis Company Has Successful Maiden Run Using Extraction Technology

News Update
  ()
The procedure resulted in two types of cannabinoids: water soluble and oil based. read more >
News Update

Biotech in Neuro Diseases Adds Parkinson's Expert to Scientific Advisory Board

News Update
  ()
The expert brings to the board a deep knowledge of neurodegeneration. read more >

Biotech Reports 'Eye-Catching, Topline Results' from RSV Vaccine Study

Research Report
  ()
The data and how the asset stacks up to others were covered in a ROTH Capital Partners report. read more >

Precision Medicine Firm Announces 'Positive' Data in Lymphoma Study

Research Report
  ()
The highlights of the results were presented in an H.C. Wainwright & Co. report. read more >
News Update

Cannabis Producer Achieves Commercial Sale Milestone

News Update
  ()
The transaction marks the start of a revenue stream for the company. read more >
News Update

Biopharma Advances Dose Escalation Trial in Alcoholic Hepatitis

News Update
  ()
The company received approval to proceed with the next and final dose level. read more >
News Update

Developer of Animal Nutrition Supplements to Form JV for Online Product Sales

News Update
  ()
The new partner has expertise in online marketing and e-commerce. read more >

Biotech Receives FDA Approval of Second-Generation Medical Device

Research Report
  ()
The product's improvements and the company's commercialization approach were summarized in a Ladenburg Thalmann report. read more >

Interim Results Put Biopharma with Tenbagger Potential 'Back on the Map'

Research Report
  ()
A key upcoming catalyst and the impact of recent positive trial results are addressed in a ROTH Capital Partners report. read more >
News Update

Healthcare Tech Firm Expands Medical Client Base in Texas

News Update
  ()
These new customers' patient accounts are already being imported into the company's platform. read more >
News Update

Biotech to Present Alzheimer's Disease Therapeutic at Keystone Symposium

News Update
  ()
The focus will be the Canadian company's lead monoclonal antibody candidate. read more >

Bacteria Test Developer Reiterates Revenue Should Double in 2019

Research Report
  ()
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. read more >
News Update

Canadian Cannabis Firm Featured in Investorideas.com 'Potcast'

News Update
  ()
The company's recent deal, progress on its cannabis beverages and its product ideas for the future were discussed. read more >

Coverage Initiated on Biotech Whose Therapies 'Can Compete with CAR-Ts'

Research Report
  ()
The reasons for the Buy rating on the U.K. firm are delineated in a ROTH Capital Partners report. read more >

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

Research Report
  ()
An explanation of the categorization and its implications are provided in a Paradigm Capital report. read more >
News Update

Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses

News Update
  ()
The offering should facilitate a more individualized treatment plan for patients. read more >

Biopharma's LDL Cholesterol-Lowering Drug Emerges as 'Lead Stallion in Safety'

Research Report
  ()
The interim study results for an in-progress trial evaluating this asset are discussed in a ROTH Capital Partners report. read more >
News Update

Biotech Identifies Antibodies for Toxic Tau in Alzheimer's Disease

News Update
  ()
The Canadian company's approach to this indication is now twofold. read more >

California-Based Biopharma Signs Licensing Deal for Acquired Asset

Research Report
  ()
The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report. read more >

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

Research Report
  ()
The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. read more >

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

Research Report
  ()
The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. read more >

U.S. Biopharma's 'Biggest Stock Moving Event' Imminent

Research Report
  ()
With study results from this company due out shortly, an analysis of the possible outcomes was provided in a ROTH Capital Partners report. read more >

Cancer Fighter Sesen Bio Leaps 13% on FDA Decision

  ()
Shares of this biotech stock were up significantly at the close of trading on Tuesday, May 21, attributed to the announcement of some good news from the FDA. read more >
News Update

Firm Takes Steps to Launch Recreational Cannabis Brand

News Update
  ()
The company continues to make preparations while it awaits receipt of a sales license. read more >

Harrow Comes Out of Allergan Lawsuit Unscathed

Contributed Opinion
  ()
Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive." read more >
Showing Results: 1 to 25 of 109 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe